Paracetamol 120mg/5ml Oral Suspension
Out of date information, search anotherSUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Junior Paracetamol Suspension
Boots Pain Relief Paracetamol Suspension 3 Months Plus Galpamol for Children Paracetamol 120mg/5ml Oral Suspension Infant’s & Children’s Paracetamol Suspension
Boots Paracetamol Sachets 3 Months Plus 120 mg/5 ml Oral Suspension
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Paracetamol BP 120 mg/ 5 ml
3 PHARMACEUTICAL FORM
Oral Suspension.
4 CLINICAL PARTICULARS
4.1 Therapeutic indications
For relief of mild to moderate pain including teething pain, and for pyrexia.
4.2 Posology and method of administration
For oral administration. It is important to shake the bottle for at least 10 seconds before use.
For children aged 3 months to 12 years:
|
Child’s Age |
How Much |
How often (in 24 hours) |
|
3 - 6 |
One 2.5 mL spoonful (small |
4 times |
|
months |
end) | |
|
6 - 24 |
One 5 mL spoonful (large |
4 times |
|
months |
end) | |
|
2 - 4 years |
One 5.0 mL spoonful (large |
4 times |
|
end) and one 2.5 mL spoonful (small end) | ||
|
4 - 8 years |
Two 5 mL spoonfuls (large end) |
4 times |
|
8 - 10 years |
Three 5 mL spoonfuls (large end) |
4 times |
|
10 - 12 years |
Four 5 mL spoonfuls (large end) |
4 times |
|
• Do not give more than 4 doses in any 24 hour period • Leave at least 4 hours between doses • Do not give this medicine to your child for more than 3 days without speaking to your doctor or pharmacist | ||
For infants aged less than 3 months:
|
Age |
Dose |
|
For post-vaccination fever for babies aged between 2 - 3 months |
One 2.5 mL spoonful (small end) If necessary, after 4-6 hours, give a second 2.5 mL dose |
|
• Do not give to babies less than 2 months of age • Do not give more than 2 doses • Leave at least 4 hours between doses • If further doses are needed, talk to your doctor or pharmacist | |
4.3 Contraindications
Contra-indicated in patients with a known hypersensitivity to paracetamol or any of the other constituents.
4.4 Special warnings and precautions for use
Paracetamol should be used with care in patients with severe renal or hepatic impairment. The hazard of overdose is greater in those with non-cirrhotic alcoholic liver disease.
Patients should be advised not to take other paracetamol containing products concurrently.
The label should contain the following statements:
• Contains paracetamol.
• Do not give this medicine with any other paracetamol-containing product.
• For oral use only.
• Never give more medicine than shown in the table.
• Do not overfill the spoon.
• Always use the spoon supplied with the pack.
• Do not give to babies less than 2 months of age
• For infants 2-3 months no more than 2 doses should be given.
• Do not give more than 4 doses in any 24 hour period.
• Leave at least 4 hours between doses.
• Do not give this medicine to your child for more than 3 days without speaking to your doctor or pharmacist.
• As with all medicines, if your child is currently taking any medicine consult your doctor or pharmacist before taking this product.
• Do not store above 25°C. Store in the original package.
• Keep out of the reach and sight of children.
event of an overdose,
event of an overdose, delayed, serious liver
• Immediate medical advice should be sought in the even if the child seems well (label).
• Immediate medical advice should be sought in the even if the child seems well, because of the risk of damage (leaflet).
4.5 Interaction with other medicinal products and other forms of interaction
The speed of absorption of paracetamol may be increased by metoclopramide or domperidone; and absorption reduced by cholestyramine.
The anti-coagulant effect of warfarin and other coumarins may be enhanced by prolonged regular use of paracetamol with increased risk of bleeding; occasional doses have no significant effect.
4.6 Fertility, Pregnancy and lactation
Epidemiological studies in human pregnancy have shown no ill effects due to paracetamol used in the recommended dosage, but patients should follow the advice of their doctor regarding its use.
Paracetamol is excreted in breast milk but not in a clinically significant amount. Available published data do not contra-indicate breast feeding.
4.7 Effects on ability to drive and use machines
None
4.8 Undesirable effects
Undesirable effects with paracetamol are rare, however, hypersensitivity including skin rashes may occur. There have been a few reports of blood dyscrasias including thrombocytopenia, and agranulocytosis but these were not necessarily causally related to paracetamol.
4.9 Overdose
Early symptoms of paracetamol overdosage include pallor, nausea, vomiting, anorexia and abdominal pain. Liver damage may become apparent 12 to 48 hours after ingestion. Abnormalities of glucose metabolism and metabolic acidosis may occur. In severe poisoning hepatic failure may progress to encephalopathy, coma and death. Acute renal failure with acute tubular necrosis may develop even in the absence of severe liver damage. Cardiac arrhythmias and pancreatitis have been reported. Liver damage is possible in adults who have taken 10g of more of paracetamol. It is considered that excess quantities of a toxic metabolite (usually adequately detoxified by glutathione when normal doses of paracetamol are ingested), become irreversibly bound to liver tissue.
Immediate treatment is essential in the management of paracetamol overdose. Despite a lack of significant early symptoms, patients should be referred to hospital urgently for immediate medical attention. Any patient who has ingested around 7.5g or more of paracetamol in the preceding 2 hours should undergo gastric lavage. Administration of oral methionine or intravenous n-acetylcysteine which may have a beneficial effect up to at least 48 hours after the overdose, may be required. General supportive measures must be available.
5 PHARMACOLOGICAL PROPERTIES
5.1 Pharmacodynamic properties
Paracetamol has analgesic and antipyretic actions probably due to the inhibition of prostaglandin biosynthesis.
5.2 Pharmacokinetic properties
Paracetamol is readily absorbed from the gastro-intestinal tract and peak plasma concentrations usually occur 30 minutes to 2 hours after ingestion. Paracetamol is metabolised in the liver and largely excreted in the urine as sulphate and glucuronide conjugates. Less than 5% is excreted unchanged. The elimination half-life varies from about 1 to 4 hours.
5.3 Preclinical safety data
None stated
6 PHARMACEUTICAL PARTICULARS
6.1 List of excipients
Glycerol; Dispersible Cellulose; Sodium Methylparaben; Sodium Propylparaben; Citric Acid Anhydrous; Saccharin Sodium; Strawberry Flavour D3694 (containing Propylene Glycol); Acesulphame K; Carmine Extract P4011 (containing Carmine, Glycerine, Potassium Hydroxide); Hydrogenated Glucose Syrup; Xanthan Gum; Purified Water.
6.2 Incompatibilities
None
6.3 Shelf life
2 years
6.4 Special precautions for storage
Store at or below 25 °C. Do not refrigerate. Protect from light.
6.5 Nature and contents of container
Amber glass or PET bottles with polyethylene child resistant screw closures, containing 70, 100, 150 or 200 ml.
5ml unit dose foil laminate sachets sold individually or packed into cartons containing 4, 5, 8, 10, 12, 15, 16, 20, 24, 25, 48, 50, 70, 96 or 100.
6.6 Special precautions for disposal
Not applicable
7. MARKETING AUTHORISATION HOLDER
Galpharm Healthcare Limited
Wrafton
Braunton
Devon
EX33 2DL
United Kingdom
8 MARKETING AUTHORISATION NUMBER(S)
PL 16028/0118
9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
27/07/1995 / 23/02/2009
10 DATE OF REVISION OF THE TEXT
10/02/2014